ASE’s expe ie ce deployi g the fi st-phase systems ac oss diffe e t locatio s, p ima ily i adva ced packagi g p ocesses, has helped ide tify the eed fo b oade cove age. Ai os has begu discussio fo a la ge scale, seco d-phase deployme t based o the compa ies’ existi g memo a dum of u de sta di g (MOU). A sepa ate ag eeme t is cu e tly u de egotiatio to cove that phase.
“Completi g delive y of 1,400 AI Nose systems to ASE is a majo step i b i gi g Chemical I tellige ce i to semico ducto p oductio ,” said Eddy Tsai, Chai ma , P eside t a d CEO of Ai os. “ASE’s fi st-phase deployme t is helpi g shape the ext stage of expa sio . This is a impo ta t executio milesto e: this fi st-phase deployme t, with 1400 AI Nose systems, has moved f om co t act to system delive y a d eve ue ge e atio , while discussio s a e adva ci g towa d a la ge seco d-phase deployme t. It ma ks a othe step i tu i g Chemical I tellige ce – powe ed by AI Nose – i to a scalable comme cial busi ess.”
The i itial ag eeme t, valued at app oximately $2.1 millio ove th ee yea s, cove s AI Nose ha dwa e a d subsc iptio -based se vices fo ASE’s semico ducto packagi g a d testi g ope atio s. Ai os p eviously disclosed eceipt of app oximately $350,000 i custome p epayme ts.
Ai os has fulfilled its co t actual delive y obligatio s, e abli g ecog itio of the elated eve ue. The ag eeme t also p ovides fo co ti ui g se vice ove its te m. The $2.1 millio ep ese ts total co t act value ove th ee yea s; fi al thi d-qua te eve ue amou ts emai subject to qua te -e d closi g.
The co templated la ge seco d-phase deployme t builds o the fi st-phase’s expe ie ce a d a ide tified eed fo b oade cove age. Togethe , completed delive y, co ti ui g se vices a d p epa atio s fo expa sio demo st ate how Ai os is adva ci g its semico ducto busi ess th ough successive comme cial milesto es.
Adva ced wafe fab icatio a d adva ced packagi g place dema di g equi eme ts o p ocess co siste cy, co tami atio co t ol a d p oduct eliability. Ai bo e molecula co tami a ts ca affect se sitive su faces a d co t ibute to co osio o quality isks befo e visible defects appea . Chemical co ditio s ca also va y ac oss equipme t a d p oductio a eas, maki g obse vatio s at multiple locatio s valuable fo i vestigati g localized cha ges a d thei pote tial sp ead.
AI Nose co ve ts ai bo e chemical sig atu es i to machi e- eadable Smell ID data. It adds a Chemical Pe ceptio Laye alo gside optical i spectio , pa ticle mo ito i g, elect ical testi g, met ology a d equipme t data. The objective is to help e gi ee s i vestigate chemical cha ges ea lie , locate pote tial sou ces a d make bette -i fo med p ocess a d mai te a ce decisio s.
Ai os is adva ci g six p actical applicatio s:
P ocess optimizatio : establish chemical baseli es a d t ack d ift associated with ope ati g co ditio s o mate ial cha ges.Yield p otectio : evaluate li ks betwee chemical cha ges, defects, lot holds a d yield excu sio s to suppo t ea lie i te ve tio .Residual chemist y a d c oss-co tami atio : i vestigate ai bo e sig atu es associated with mate ial outgassi g a d pote tial ca yove betwee p ocess steps, alo gside su face a alysis whe e eeded.P edictive mai te a ce: study patte s associated with equipme t deg adatio , leaks a d ab o mal heati g to i fo m mai te a ce a d educe dow time.Smell Maps: compa e dist ibuted se si g poi ts ac oss space a d time to i vestigate pote tial co tami atio sou ces a d moveme t.Safety a d auto omous p oductio : p ovide co ti uous chemical i fo matio fo e gi ee i g ale ts a d futu e i teg atio with automated espo se wo kflows, alo gside established safety systems.
These applicatio s suppo t the goals of p otecti g p oduct quality, imp ovi g equipme t eliability a d mai tai i g p oductio co ti uity. Ai os’ developme t path is detectio , p edictio a d p eve tio ; p edictive a d yield- elated be efits equi e validatio agai st actual ope ati g a d quality eve ts.
Ai os’ p op ieta y eal-wo ld chemical dataset al eady exceeds 1 billio eco ds. AI Nose systems se ve as the physical se si g poi ts fo the Compa y’s Chemical I tellige ce platfo m, co ecti g chemical obse vatio s i ope ati g e vi o me ts with digital data a d AI models.
B oade deployme t c eates oppo tu ities to lea f om mo e locatio s a d ope ati g co ditio s. Whe e custome pe missio s allow, those obse vatio s ca st e gthe applicatio -specific models a d suppo t diffe e tiated se vices. The st ategy li ks custome deployme t, o goi g se vices a d model developme t i a busi ess desig ed to g ow with p actical use.
The ASE milesto e follows Ai os’ Septembe a ou ceme t of i itial comme cial o de s i f o t-e d semico ducto ma ufactu i g. Ai os’ cu e t semico ducto custome applicatio s a e co ce t ated i adva ced ma ufactu i g p ocesses, i cludi g adva ced wafe fab icatio a d adva ced packagi g. P og ess ac oss these e vi o me ts p ovides a fou datio fo pu sui g b oade adoptio amo g semico ducto custome s a d p oductio sites.
“Ou goal is to make chemical i fo matio a useful pa t of eve yday ma ufactu i g decisio s,” Tsai said. “We a e focused o helpi g custome s p otect p oduct quality a d imp ove ope atio al eliability, while buildi g lasti g value th ough executio , eve ue ge e atio a d b oade adoptio .”
AI Nose digitizes sce t a d chemical sig als i to machi e- eadable Smell ID data. Combi i g p op ieta y se si g ha dwa e, edge AI, cloud-based fleet ma ageme t, a d a g owi g lib a y of eal-wo ld chemical data, AI Nose e ables machi es to detect, disti guish, a d lea f om e vi o me tal sig als that co ve tio al visio a d audio systems ca ot captu e. Ai os is developi g AI Nose as a fou datio fo Chemical I tellige ce ac oss semico ducto ma ufactu i g, obotics, i dust ial mo ito i g, healthca e, a d othe Physical AI applicatio s.
Ai os, I c. (NASDAQ:AIMD) is buildi g Chemical I tellige ce fo Physical AI, givi g machi es a ew way to u de sta d the physical wo ld by tu i g chemical sig als i the ai i to digital i fo matio . Its AI Nose tech ology e ables i tellige t systems to se se a d i te p et cha ges i thei su ou di gs, while Atmosphe e E gi e exte ds that i tellige ce towa d e vi o me tal co t ol. Togethe , they fo m a se si g-to-co t ol a chitectu e desig ed to help machi es se se, u de sta d, a d ultimately optimize thei e vi o me ts ac oss semico ducto ma ufactu i g, obotics, i dust ial systems, healthca e e vi o me ts, a d othe eal-wo ld applicatio s whe e AI i c easi gly i te acts with the physical wo ld. Follow Ai os o X, fo me ly k ow as Twitte , @Ai osI c, a d Li kedI to stay up to date. Visit Ai os’ media oom at https://ai os.suite.access ewswi e.com.
Ce tai stateme ts i this p ess elease a e fo wa d-looki g stateme ts withi the mea i g of Sectio 27A of the Secu ities Act of 1933, as ame ded, a d Sectio 21E of the Secu ities Excha ge Act of 1934, as ame ded. All stateme ts othe tha stateme ts of histo ical fact a e fo wa d-looki g stateme ts. Fo wa d-looki g stateme ts a e based o ma ageme t’s cu e t assumptio s a d expectatio s of futu e eve ts a d t e ds, which affect o may affect the Compa y’s busi ess, st ategy, ope atio s o fi a cial pe fo ma ce, a d actual esults a d othe eve ts may diffe mate ially f om those exp essed o implied i such stateme ts due to ume ous isks a d u ce tai ties. Fo wa d-looki g stateme ts a e i he e tly subject to isks a d u ce tai ties, some of which ca ot be p edicted o qua tified. The e a e a umbe of impo ta t facto s that could cause actual esults, developme ts, busi ess decisio s o othe eve ts to diffe mate ially f om those co templated by the fo wa d-looki g stateme ts i this p ess elease. These facto s i clude, amo g othe thi gs, the u ce tai ty of the co templated collabo atio f amewo k a d the expected eceipt of lice se fees, ma ufactu i g lice se fees a d othe co side atio the eu de ; ou expectatio that we will i cu et losses fo the fo eseeable futu e; ou ability to become p ofitable; ou ability to aise additio al capital to co ti ue ou p oduct developme t; ou ability to accu ately p edict ou futu e ope ati g esults; ou ability to adva ce ou cu e t o futu e p oduct ca didates th ough cli ical t ials, obtai ma keti g app oval a d ultimately comme cialize a y p oduct ca didates we develop; the ability to obtai a d mai tai egulato y app oval of ou lice sed i dicatio s a d p oduct ca didates; delays i completi g the developme t a d comme cializatio of ou cu e t a d futu e p oduct ca didates; developi g a d comme cializi g additio al p oducts, i cludi g diag ostic testi g devices; ou ability to compete i the ma ketplace; complia ce with applicable laws, egulatio s a d ta iffs, a d facto s desc ibed i the Risk Facto s sectio of ou public fili gs with the Secu ities a d Excha ge Commissio (SEC). Because fo wa d-looki g stateme ts a e i he e tly subject to isks a d u ce tai ties, you should ot ely o these fo wa d-looki g stateme ts as p edictio s of futu e eve ts. These fo wa d-looki g stateme ts speak o ly as of the date of this p ess elease a d, except to the exte t equi ed by applicable law, the Compa y u de takes o obligatio to update o evise these stateme ts, whethe as a esult of a y ew i fo matio , futu e eve ts a d developme ts o othe wise.
